Growth Metrics

BioNexus Gene Lab (BGLC) Other Working Capital Changes (2018 - 2025)

BioNexus Gene Lab's Other Working Capital Changes history spans 8 years, with the latest figure at -$7700.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$7700.0 for Q4 2025, up 58.5% from a year ago — trailing twelve months through Dec 2025 was -$34511.0 (up 19.55% YoY), and the annual figure for FY2025 was -$34511.0, up 19.55%.
  • Other Working Capital Changes for Q4 2025 was -$7700.0 at BioNexus Gene Lab, up from -$13410.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $98018.0 in Q3 2023 to a low of -$104876.0 in Q4 2022.
  • The 5-year median for Other Working Capital Changes is -$10628.0 (2022), against an average of -$7770.6.
  • The sharpest move saw Other Working Capital Changes soared 1022.26% in 2023, then tumbled 545.95% in 2025.
  • Year by year, Other Working Capital Changes stood at -$20169.0 in 2021, then crashed by 419.99% to -$104876.0 in 2022, then skyrocketed by 94.88% to -$5369.0 in 2023, then tumbled by 245.56% to -$18553.0 in 2024, then surged by 58.5% to -$7700.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$7700.0, -$13410.0, and $60514.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.